Integral Health Asset Management, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Integral Health Asset Management, LLC disclosed 70 US equity positions worth $1.1bn in its Q2 2025 13F filing. The largest position was INSM at 15.0% of the reported book, followed by BSX and THC. Against the Q1 2025 filing, it opened 12 new positions, added to 21 and reduced 10 among the top 50 holdings.
What did Integral Health Asset Management, LLC own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 15.0% | $161.0m | 1,600,000 | 3% | added |
| 2 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 5.5% | $59.1m | 550,000 | -15% | reduced |
| 3 | THC TENET HEALTHCARE CORP | Healthcare | 4.5% | $48.4m | 275,000 | 0% | held |
| 4 | EHC ENCOMPASS HEALTH CORP | Healthcare | 3.7% | $39.2m | 320,000 | 19% | added |
| 5 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 3.4% | $36.5m | 2,700,000 | 17% | added |
| 6 | CYTK CYTOKINETICS INC | Healthcare | 3.1% | $33.0m | 1,000,000 | -9% | reduced |
| 7 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 2.8% | $29.5m | 1,250,000 | 61% | added |
| 8 | VERA VERA THERAPEUTICS INC | Healthcare | 2.5% | $27.1m | 1,150,000 | 0% | held |
| 9 | DGX QUEST DIAGNOSTICS INC | Healthcare | 2.5% | $26.9m | 150,000 | – | new |
| 10 | REGN REGENERON PHARMACEUTICALS | Healthcare | 2.5% | $26.2m | 50,000 | – | new |
| 11 | NVS NOVARTIS AG | Healthcare | 2.3% | $24.2m | 200,000 | -20% | reduced |
| 12 | CAH CARDINAL HEALTH INC | Healthcare | 2.2% | $23.5m | 140,000 | – | new |
| 13 | ELV ELEVANCE HEALTH INC | Healthcare | 2.2% | $23.3m | 60,000 | -8% | reduced |
| 14 | RDNT RADNET INC | Healthcare | 2.1% | $22.8m | 400,000 | 60% | added |
| 15 | FMS FRESENIUS MEDICAL CARE AG | Healthcare | 2.0% | $21.4m | 750,000 | 10% | added |
| 16 | LLY ELI LILLY & CO | Healthcare | 1.8% | $19.5m | 25,000 | – | new |
| 17 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.8% | $18.9m | 150,000 | 0% | held |
| 18 | QURE UNIQURE NV | 1.8% | $18.8m | 1,350,000 | 8% | added | |
| 19 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.7% | $17.9m | 55,000 | 10% | added |
| 20 | DXCM DEXCOM INC | Healthcare | 1.6% | $17.5m | 200,000 | 100% | added |
| 21 | CRL CHARLES RIV LABS INTL INC | Healthcare | 1.6% | $17.4m | 115,000 | – | new |
| 22 | MDT MEDTRONIC PLC | Healthcare | 1.6% | $17.4m | 200,000 | -33% | reduced |
| 23 | CVS CVS HEALTH CORP | Healthcare | 1.6% | $17.2m | 250,000 | 25% | added |
| 24 | PFE PFIZER INC | Healthcare | 1.6% | $17.0m | 700,000 | 133% | added |
| 25 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 1.5% | $15.6m | 200,000 | 60% | added |
| 26 | GEHC GE HEALTHCARE TECHNOLOGIES I | Healthcare | 1.4% | $14.8m | 200,000 | 33% | added |
| 27 | AZN ASTRAZENECA PLC | Healthcare | 1.3% | $14.0m | 200,000 | – | new |
| 28 | EWTX EDGEWISE THERAPEUTICS INC | 1.2% | $13.1m | 1,000,000 | 48% | added | |
| 29 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.2% | $12.7m | 1,250,000 | – | new |
| 30 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.1% | $12.0m | 325,000 | 30% | added |
| 31 | ETNBGBP 89BIO INC | 1.0% | $10.3m | 1,050,000 | 0% | held | |
| 32 | PEN PENUMBRA INC | Healthcare | 1.0% | $10.3m | 40,000 | 14% | added |
| 33 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.9% | $9.4m | 200,000 | 0% | held |
| 34 | INSP INSPIRE MED SYS INC | Healthcare | 0.8% | $9.1m | 70,000 | 8% | added |
| 35 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 0.8% | $9.1m | 400,000 | 60% | added |
| 36 | BEAM BEAM THERAPEUTICS INC | Healthcare | 0.8% | $8.5m | 500,000 | – | new |
| 37 | HO1 HOLOGIC INC | 0.8% | $8.1m | 125,000 | – | new | |
| 38 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 0.8% | $8.1m | 200,000 | 0% | held |
| 39 | RZLT REZOLUTE INC | 0.7% | $8.0m | 1,800,000 | 260% | added | |
| 40 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 0.7% | $7.6m | 120,000 | – | new |
| 41 | BAX BAXTER INTL INC | Healthcare | 0.7% | $7.6m | 250,000 | -50% | reduced |
| 42 | ABBV ABBVIE INC | Healthcare | 0.7% | $7.4m | 40,000 | -33% | reduced |
| 43 | MCK MCKESSON CORP | Healthcare | 0.7% | $7.3m | 10,000 | -17% | reduced |
| 44 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.6% | $6.8m | 600,000 | 0% | held |
| 45 | IRTC IRHYTHM TECHNOLOGIES INC | Healthcare | 0.6% | $6.2m | 40,000 | – | new |
| 46 | A AGILENT TECHNOLOGIES INC | Healthcare | 0.6% | $5.9m | 50,000 | – | new |
| 47 | RGNX REGENXBIO INC | Healthcare | 0.5% | $5.7m | 700,000 | -24% | reduced |
| 48 | VRNA VERONA PHARMA PLC | 0.5% | $5.7m | 60,000 | -48% | reduced | |
| 49 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 0.5% | $5.6m | 400,000 | 100% | added |
| 50 | ATYR ATYR PHARMA INC | Healthcare | 0.5% | $5.3m | 1,050,000 | 50% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.